Biologics Market Research Reports & Industry Analysis
The biologics industry includes a wide range of therapeutic products derived from biological sources and is a fundamental part of modern healthcare. Biologics play a vital role in advancing treatments for various diseases and conditions. MarketResearch.com offers a comprehensive collection of biologics industry reports to provide valuable insights into the most recent market trends, challenges, and opportunities to watch.
Biologics Market Growth Forecasts
- Access detailed information about a variety of distinct market segments, such as recombinant proteins, vaccines, and more.
- Obtain biologics market sizing and growth projections to gain a clear understanding of market potential and outlook.
- Analyze leading players and competitor strategies to stay one step ahead in a competitive market.
The MarketResearch.com Advantage
MakretResearch.com has been a trailblazer in the field of market research for more than two decades and continues to serve many of the largest life science and biotech companies in the world. With MarketResearch.com’s reliable data-driven insights, you can make informed decisions to guide your business towards success. Choose MarketResearch.com and gain the edge today.
Biologics Industry Research & Market Reports
-
2024 Global Forecast for Biologics Contract Development Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD ... Read More
-
2024 Global Forecast for Compound Management Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD xx ... Read More
-
Biologics and Biosimilars Industry Research Report 2024
... proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is ... Read More
-
Global Biologics and Biosimilars Market Size, Manufacturers, Opportunities and Forecast to 2030
... biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. ... Read More
-
Global Biologics and Biosimilars Market Analysis and Forecast 2024-2030
... proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. A biosimilar in ... Read More
-
Global Biologics and Biosimilars Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but ... Read More
-
Global Biologics and Biosimilars Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a ... Read More
-
Global Wound Care Biologics Databank Market Report
... 2023 to 2031. Ulcers segment is expected to be the highest contributor to this market, with $730.2 Million in 2022, and is anticipated to reach $1,212.3 Million by 2031, registering a CAGR of 5.84%. Surgical ... Read More
-
Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325414
... Averages and Top Companies Within Its Industry, and Revenue Forecasts to 2030, NAIC 325414 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: ... Read More
-
Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325412
... Top Companies Within Its Industry, and Revenue Forecasts to 2030, NAIC 325412 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Pharmaceuticals, Biopharmaceuticals, ... Read More
-
Cell Culture Market Size, Trends, Analysis, and Outlook By Product (Consumables, Instruments), By Application (Biopharmaceutical Production, Drug Development, Diagnostics, Tissue Culture & Engineering, Cell and Gene Therapy, Toxicity Testing, Others), by Country, Segment, and Companies, 2024-2032
... 2024-2032 The global Cell Culture market size is poised to register 12.8% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Cell Culture ... Read More
-
Culture Media Market Size, Trends, Analysis, and Outlook By Type (Lysogeny broth, Chemically defined media, Classical Media, Serum-free Media, Specialty Media, Stem Cell Media, Custom Media Formulation, Others), By Application (Cancer Research, Biopharmaceuticals, Regenerative Medicine & Tissue Engineering, Stem Cell Technologies, Drug Discovery, Others), By Research (Cytogenetics, Cell Therapy, Others), By End-User (Biotechnology and Pharmaceutical Industry, Academic Institute, Research Laboratory, Others), by Country, Segment, and Companies, 2024-2032
... & Tissue Engineering, Stem Cell Technologies, Drug Discovery, Others), By Research (Cytogenetics, Cell Therapy, Others), By End-User (Biotechnology and Pharmaceutical Industry, Academic Institute, Research Laboratory, Others), by Country, Segment, and Companies, 2024-2032 The global Culture ... Read More
-
Healthcare IT Outsourcing Market Size, Trends, Analysis, and Outlook By Type (Payers, Providers), By End-User (Healthcare Provider System, Biopharmaceutical Industry, Clinical Research Organization, Others), by Country, Segment, and Companies, 2024-2032
... market size is poised to register 16.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Healthcare IT Outsourcing market across By Type ... Read More
-
Cell Culture Media Market Size, Trends, Analysis, and Outlook By Type (Serum-free Media, Classical Media & Salts, Stem Cell Culture Media, Specialty Media, Chemically defined Media, Others), By Application (Biopharmaceutical Production, Diagnostics, Drug Screening & Development, Tissue Engineering & Regenerative Medicine, Others), By End-User (Pharmaceutical & Biotechnology Companies, Hospitals, Diagnostic Laboratories, Academic Institutes, Others), by Country, Segment, and Companies, 2024-2032
... Development, Tissue Engineering & Regenerative Medicine, Others), By End-User (Pharmaceutical & Biotechnology Companies, Hospitals, Diagnostic Laboratories, Academic Institutes, Others), by Country, Segment, and Companies, 2024-2032 The global Cell Culture Media market size is poised to ... Read More
-
Specialty Injectable Generics Market Size, Trends, Analysis, and Outlook By Type (Drugs, Biologics), By Application (Oncology, Cardiovascular, Infectious Diseases, Central Nervous Systems, Autoimmune Disorders, Others), by Country, Segment, and Companies, 2024-2032
... Generics market size is poised to register 8.6% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Specialty Injectable Generics market across By ... Read More
-
Biologics CDMO Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... billion by 2029, growing at a CAGR of 12.78% during the forecast period (2024-2029). With an increasing number of companies within the pharmaceutical sector considering outsourcing services, the demand for services from contract manufacturing and ... Read More
-
Biopharmaceutical Contract Manufacturing Market Size, Trends, Analysis, and Outlook By Product (Biologics, Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAi & Molecular Therapy, Biosimilars), By Source (Mammalian, Non-Mammalian), By Service (Process Development, Fill And Finish Operations, Analytical And QC Studies, Packaging), By Application (Clinical, Commercial), by Country, Segment, and Companies, 2024-2032
... Operations, Analytical And QC Studies, Packaging), By Application (Clinical, Commercial), by Country, Segment, and Companies, 2024-2032 The global Biopharmaceutical Contract Manufacturing market size is poised to register 8.3% growth from 2024 to 2032, presenting significant ... Read More
-
Rare Neurological Disease Treatment Market Size, Trends, Analysis, and Outlook By Drug (Biologics, Small Molecules), By Route of Administration (Intravenous, Oral), by Country, Segment, and Companies, 2024-2032
... is poised to register 8.9% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Rare Neurological Disease Treatment market across By Drug (Biologics, ... Read More
-
Human Insulin Market Size, Trends, Analysis, and Outlook By Product (Drugs, Delivery Devices), By Drug (Insulin Analogs and Biosimilars, Human Insulin Biologics), By Brand (Insulin Analogs and Biosimilars, Human Insulin Biologics, Insulatard, Mixtard), By Delivery Device (Pens, Pen Needles, Syringes), by Country, Segment, and Companies, 2024-2032
... Device (Pens, Pen Needles, Syringes), by Country, Segment, and Companies, 2024-2032 The global Human Insulin market size is poised to register 4.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in ... Read More
-
Biotechnology Contract Manufacturing Market Size, Trends, Analysis, and Outlook By Service (Manufacturing, Formulation and Fill-Finish, Packaging and Labeling, Others), By Type (Biologic Drug Substance Manufacturing, Biologic Drug Product Manufacturing), By Scale of Operation (Commercial Operations, Clinical Operations), By Source (Mammalian Expression Systems, Non-Mammalian Expression Systems), By Molecule (Monoclonal Antibodies, Cell Therapy & Gene Therapy, Antibody-Drug Conjugates (ADCs), Vaccines, Therapeutic Peptides & Proteins, Others), By Indication (Oncology, Autoimmune Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Neurology, Others), by Country, Segment, and Companies, 2024-2032
... Clinical Operations), By Source (Mammalian Expression Systems, Non-Mammalian Expression Systems), By Molecule (Monoclonal Antibodies, Cell Therapy & Gene Therapy, Antibody-Drug Conjugates (ADCs), Vaccines, Therapeutic Peptides & Proteins, Others), By Indication (Oncology, Autoimmune Diseases, Cardiovascular Diseases, ... Read More
-
Healthcare Distribution Market Size, Trends, Analysis, and Outlook By Product (Pharmaceutical Product Distribution Services, Biopharmaceutical Product Distribution Service, Medical Devices Distribution Services), By End-User (Retail Pharmacies, Hospital Pharmacies, Others), by Country, Segment, and Companies, 2024-2032
... The global Healthcare Distribution market size is poised to register 7.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Healthcare Distribution market ... Read More
-
Bioprocessing Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
... (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & ... Read More
-
Cell Culture Media Market – By Product Type (Serum-free Media {CHO, HEK 293, BHK}, Stem-cell Culture Media), Application (Biopharmaceutical Production {Vaccine, Monoclonal Antibodies}, Diagnostics), End-user – Global Forecast (2024 – 2032)
... size is projected to expand at 12.8% CAGR from 2024 to 2032. The rising demand for biopharmaceuticals, such as vaccines and monoclonal antibodies is necessitating the use of high-quality cell culture media in production processes. ... Read More
-
Glioblastoma Multiforme Treatment Market Report by Drug Type (Temozolomide, Bevacizumab, Carmustine, Radiosensitizers, and Others), Route of Administration (Oral, Parenteral), Type of Molecule (Small Molecule, Biologics), Distribution Channel (Hospitals, Pharmacies, and Others), and Region 2024-2032
... global glioblastoma multiforme treatment market size reached US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032. ... Read More
-
Single-Use Bioprocessing Market Report by Product Type (Media Bags and Containers, Filtration Assemblies, Single-Use Bioreactors, Disposable Mixers, and Others), Application (Filtration, Storage, Cell Culture, Mixing, Purification), End-Use (Upstream, Fermentation, Downstream), End-User (Biopharmaceutical Manufacturers, Life Science R&D, and Others), and Region 2024-2032
... R&D, and Others), and Region 2024-2032 The global single-use bioprocessing market size reached US$ 16.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 64.5 Billion by 2032, exhibiting a growth ... Read More
Research Assistance
